Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis
Conditions: Systemic Sclerosis; Gastroesophageal Reflux; Proton Pubm Inhibitor Intervention: Drug: Omeprazole 20mg Sponsors: Khon Kaen University; Thai Rheumatism Association Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acid Reflux | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Proton Pump Inhibitors PPIs | Research | Rheumatology | Scleroderma